EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
It was in 1934 that German chemist Karl Meyer and his British student John Palmer first isolated Hyaluronic Acid from the human body.
This year marks the 90th anniversary of the discovery of this molecule, which is used today in a large number of leading therapeutic areas and whose chemical specificities still conceal many discoveries for years to come.
To mark the occasion, HTL Biotechnology is committed to celebrating this anniversary throughout 2024. On the agenda : events and presentations on Hyaluronic Acid will guide you into the world of this fascinating molecule.
For the more curious among you, stay tuned by subscribing to the hashtag #90YearsofHAwithHTL ! 2024 is set to be a year full of learning and discovery !
On June 4th, as part of the 3rd edition of the National Biopharmaceutical Bioproduction Day (#JNBB2026) organized by France BioLead, HTL Biotechnology was pleased to open the doors of its Javené facility to students and teachers who came to learn about careers in bioproduction.
At HTL Biotechnology, a culture of safety is deeply ingrained in our daily operations and guides all of our industrial practices. It is part of a clear goal: striving for zero accidents by placing prevention at the heart of our actions.
We have renewed our EcoVadis assessment and achieved the Platinum level!